One of the most perplexing issues with regards to dengue virus infection is the finding that whereas primary infection with one serotype leads to long term protection against the same serotype, infection with a heterologous serotype leads to a wide spectrum of illness ranging from mild to severe and in some cases fatal. The mechanisms for this outcome are far from clear and provide for a major challenge to produce an effective dengue vaccine since the potential exists that the vaccine may in fact potentiate severe disease. Our lab has been studying the acute response to dengue virus in patients with dengue fever (DF) and dengue hemorrhagic fever (DHF) in attempts to delineate biological markers that can distinguish DF from DHF in an endemic population. During this process our lab has documented the following: a) early (day 1-3) during dengue infection, the plasma of these patients contain a number of cytokines and chemokines that we submit drive the mobilization of memory B cells which develop into plasma blasts and represent >50% of the B cells in the blood b) the plasma blasts are highly susceptible to apoptosis by factors in the late (day 7-10) sera of these patients and/or by their interaction with Fas-L expressing NK cells c) there is a marked increase in the frequencies of plamacytoid dendritic cells (pDC's) which express immature phenotype d) there is a muted memory B cell response against the heterologous dengue virus in these patients. Based on these preliminary findings, our lab has formulated a series of questions, which are aimed at defining in more detail the chain of immunological events that occur during acute dengue infection with the aim to define the events that are associated with disease severity. Thus, the objectives of this proposal are to carry out detailed studies of a) levels of the chemokines/cytokines that are present in the sera of dengue patients during acute infection and identify homing markers on the plasma blasts and correlate mild asymptomatic v/s severe disease b) attempt to define the mechanisms that lead to enhanced apoptosis of the plasma blasts c) examine the relationships between KIR/MHC polymorphisms that contribute to the quality of interactions between NK cell and monocytes and dendritic cells (DC's) and d) studies of the phenotypic and functional heterogeneity of monocytes/DC's that correlates with disease severity. We have assembled an outstanding team of immunologists, virologists and pediatric dengue clinicians with a long track record of working on dengue viral disease to address each of the specific aims outlined and submit that the results from these studies will not only contribute to the understanding of the pathogenesis of dengue infection but may also provide clues to effective vaccine formulation.

Public Health Relevance

Dengue viral infections are caused by 4 different viral serotypes, are transmitted by mosquitoes and are the etiological agents for 10-100 million cases per year worldwide which include 2 million with severe disease and >20,000 deaths annually. Its geographic distribution continues to expand and is now considered an emerging disease threat to the United States. There are currently no effective vaccines and/or chemotherapeutic agents against this viral disease. One of the most peculiar issues with dengue infections is that while exposure with one serotype leads to long term protection against the same serotype, exposure to different serotype DOES NOT lead to protection against the second serotype and often leads to severe disease that is some cases leads to death. Our basic hypothesis is that besides a role for host genetics, the innate immune response generated during a heterologous DENV leads to ablation of memory responses and a general skewing of the spectrum of immune response against the second serotype. This proposal seeks to identify the mechanisms of the innate immune responses that are responsible for severe disease and lack of protective immunity which we submit need to be defined before an effective therapeutic vaccine can be formulated.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
4R01AI099385-02
Application #
8486354
Study Section
Special Emphasis Panel (ZRG1-IDM-R (50))
Program Officer
Cassetti, Cristina
Project Start
2012-06-12
Project End
2017-05-31
Budget Start
2013-06-01
Budget End
2014-05-31
Support Year
2
Fiscal Year
2013
Total Cost
$133,659
Indirect Cost
$9,901
Name
Mahidol University
Department
Type
DUNS #
660984043
City
Nakhon Pathom
State
Country
Thailand
Zip Code
73170